Experts recently set out to determine whether distinct subpopulations of clonal cells with different proliferative potential exist within the same individual with CLL. The study used deuterium-labeled ...
PLEASANTON, Calif. & NANJING, China & SHANGHAI--(BUSINESS WIRE)--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company advancing the development of novel cell therapies for ...
PHILADELPHIA – The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a ...
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on ...
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on ...
B cell production is not offset by a commensurate amount of cell destruction in B-CLL. A goal for most therapeutic strategies is, therefore, the induction of apoptosis in malignant cells, but patients ...
In 1997, a 55-year-old woman with Philadelphia chromosome positive CML in the first chronic phase received allogeneic peripheral blood SCT from her HLA-identical sister following a preparative regimen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback